CompoAtlas

IMMU+M

Food supplement declared in France, declaration No 2023-4-621

IMMU+M (Pharm nature micronutrition) is a food supplement declared in France. Status: retiré du marché le 1 January 2024. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
Pharm nature micronutrition
Food business operator placing the product on the market
Pharm nature micronutrition
Status
Retiré du marché le 1 January 2024
Form
Gélule
Daily dose
1 gélule
Directions for use
Le matin à jeun, avec un verre d'eau
Objectives stated by the manufacturer (these are not authorised claims)
Immunité

Declaration 193494, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Micro-organisms

StrainPer day
Lactobacillus Acidophilus DSM 177423,500,000,000 (unit not declared)
Lactobacillus Rhamnosus DSM 216903,500,000,000 (unit not declared)
Bifidobacterium Animalis DSM 17741-LMG 235122,000,000,000 (unit not declared)
Bifidobacterium Bifidum DSM 216921,000,000,000 (unit not declared)

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Acide L-ascorbiqueVitamine Cpas de limite (données insuffisantes)180 mg

Additives

E464

Other ingredients

amidon de maïs

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : Pharm nature micronutrition

Enter to analyse, Shift+Enter for a new line